Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:45 AM
Ignite Modification Date:
2025-12-26 @ 10:19 AM
NCT ID:
NCT04843761
Pre Assignment Details:
The study includes randomization according to 4 strata:
* Stratum 1 eligible for both Aviptadil and Remdesivir (no prior Remdesivir)
* Stratum 2 eligible for Aviptadil only (Remdesivir contraindicated)
* Stratum 3 eligible for Remdesivir only (Aviptadil contraindicated)
* Stratum 4 eligible for Aviptadil and have received prior Remdesivir
This record presents enrollment data across the full study. Refer to the agent-specific records for results by agent (H1: NCT06729606; H2: NCT06729593)
Recruitment Details:
Eligibility for each agent was assessed at the same time.
If eligible for both, participants were randomized to a 2x2 factorial design of Aviptadil vs. Aviptadil placebo and Remdesivir vs. Remdesivir placebo with 1:1:1:1 allocation to each of the 4 possible combinations. If eligible for only 1, randomization was 1:1 to that agent or its matched placebo (Appendix H2).
The primary analysis for each agent was to pool across applicable groups to compare each agent vs. matched placebo.
Study:
NCT04843761
Study Brief:
Results Section:
NCT04843761